Board of Directors
Finance & Audit Committee
Research Management Committee
Scientific Advisory Committee
Commercialization & Legacy Committee
Equity, Diversity, and Inclusion Committee
Become a Member
The Equity, Diversity, and Inclusion Committee facilitates the development and maintenance of collaborative partnerships within GlycoNet to achieve a community in which group members are represented and participate equitably at all levels. The Committee works to implement the Network’s Equity, Diversity and Inclusion plan and raise awareness of inclusivity within GlycoNet.
The EDI Committee’s Terms of Reference was approved by the Board on July 8, 2020. Read the following message from the Chair of the EDI Committee:
Organizations that successfully embrace principles of equity, diversity, and inclusiveness (EDI) improve their creativity, productivity, and products. The Board of Directors of GlycoNet believes that, if we as a community support equity, diversity, and inclusiveness, we will improve the innovation and research outcomes within the network. Accordingly, the Board established the EDI Committee, which has representation from across the GlycoNet community and reports directly to the Board. Its mandate is broadly to recommend actions and programs that will enhance EDI throughout the network. In the upcoming months, we will provide you with details of activities that the EDI Committee is considering. Meanwhile, read the Terms of Reference document and initiate discussions among your colleagues about what EDI means to you.
Nils O. Petersen,
Chair, EDI Committee
Vice-Chair, Board of Directors
Canadian Glycomics Network
E5-33 Gunning/Lemieux Chemistry Centre
University of Alberta, T6G 2G2
© CANADIAN GLYCOMICS NETWORK (GLYCONET). ALL RIGHTS RESERVED.